Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$401K Buy
4,473
+596
+15% +$57.2K ﹤0.01% 1110
2025
Q4
$360K Buy
3,877
+120
+3% +$13.1K ﹤0.01% 1084
2025
Q3
$468K Buy
3,757
+115
+3% +$14.6K ﹤0.01% 998
2025
Q2
$479K Buy
3,642
+109
+3% +$12.3K ﹤0.01% 971
2025
Q1
$370K Buy
3,533
+192
+6% +$20.1K ﹤0.01% 1025
2024
Q4
$363K Buy
3,341
+331
+11% +$37K ﹤0.01% 1058
2024
Q3
$321K Buy
3,010
+100
+3% +$10.1K ﹤0.01% 1070
2024
Q2
$288K Buy
2,910
+142
+5% +$14.3K ﹤0.01% 1070
2024
Q1
$256K Buy
2,768
+11
+0.4% +$886 ﹤0.01% 1108
2023
Q4
$208K Buy
+2,757
New +$179K ﹤0.01% 1149
2021
Q3
Sell
-2,487
Closed -$249K 1207
2021
Q2
$249K Buy
+2,487
New +$231K ﹤0.01% 1113

Other funds holding ITRI

Xponance's ITRI Position: Q1 2026 in Review

Xponance increased its Itron (ITRI) stake by 15% in Q1 2026, buying an estimated $57.2K and bringing the position to 4,473 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #1110.

Xponance first reported a position in ITRI in Q2 2021 and has held it in 11 quarters since. The position peaked at $479K in Q2 2025. 431 funds tracked by Wall St. Rank hold ITRI as of Q1 2026.

  • Xponance held 4,473 shares of Itron worth $401K as of Q1 2026.
  • Xponance bought 596 Itron shares in Q1 2026, an estimated $57.2K.
  • Itron made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #1110 holding.
  • Xponance first reported a position in Itron in Q2 2021 and has held it in 11 quarters since.
  • Xponance's Itron position peaked at $479K in Q2 2025.
  • 431 funds tracked by Wall St. Rank held Itron as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.